Lansoprazol Krka

Lansoprazole, the active ingredient in Lansoprazol Krka, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal conditions such as reflux disease and ulcers. GNH USA supplies Lansoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazol Krka, a proton pump inhibitor, is used to treat several acid‑related gastrointestinal disorders. - Gastroesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication therapy: enhances the effectiveness of antibiotic regimens by suppressing acid production. - Erosive esophagitis: facilitates mucosal healing and symptom relief.

Adverse reactions may occur with Lansoprazol Krka use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, often transient. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: use with caution in liver disease. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term users: watch for bone density loss and magnesium deficiency. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at room temperature: keep below 25°C, in the original packaging, protected from moisture and light.

Lansoprazol Krka may interact with several medicines.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate: higher systemic exposure, watch for toxicity. - Digoxin: altered absorption, check serum levels.